At the last World Orphan Drug Congress Asia in 2013, the audience were fortunate to hear from Zen-Ichi Mohri of JCR Pharmaceuticals., Co Ltd.
He gave the following presentation entitled: JCR Biotech for a New Tomorrow – Challenges and Goals.
- JCR’s R&D strategy policy for rare diseases
- JCR’s 4 platform technology
- High expression gene recombination technology
- Effective cell cultivation of animals or human
- High yield purification technology for protein drugs
- High quality formulation technology for biopharmaceuticals
- Development of stem cell and corneal cell therapy